Homozygotes for the autosomal dominant neoplasia syndrome (MEN1).

Families in which both parents are heterozygotes for the same autosomal dominant neoplasia syndrome are extremely unusual. Recently, we had the unique opportunity to evaluate three symptomatic siblings from the union between two unrelated individuals affected by multiple endocrine neoplasia type 1 (MEN1). When the three siblings and their parents and relatives were genotyped for 12 markers tightly linked to the MEN1 locus, at 11q13, two of the siblings were found to be homozygotes, and one a heterozygote, for MEN1. With regard to the MEN1 syndrome, no phenotypic differences were observed between the two homozygotes and the heterozygotes. However, the two homozygotes showed unexplained infertility, which was not the case for any of the heterozygotes. Thus, MEN1 appears to be a disease with complete dominance, and the presence of two MEN1 alleles with mutations of the type that occur constitutionally may be insufficient for tumor development.

[1]  R. Thakker,et al.  Multiple endocrine neoplasia type 1 (MEN1). , 1994, European journal of cancer.

[2]  P. Woollard,et al.  Linkage analysis of 7 polymorphic markers at chromosome 11p11. 2‐11q13 in 27 multiple endocrine neoplasia type 1 families , 1993, Annals of human genetics.

[3]  J. Norton,et al.  Allelic loss from chromosome 11 in parathyroid tumors. , 1992, Cancer research.

[4]  A. Berns,et al.  Requirement for a functional Rb-1 gene in murine development , 1992, Nature.

[5]  R. Weinberg,et al.  Effects of an Rb mutation in the mouse , 1992, Nature.

[6]  A. Bradley,et al.  Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.

[7]  S. Wells,et al.  A minisatellite and a microsatellite polymorphism within 1.5 kb at the human muscle glycogen phosphorylase (PYGM) locus can be amplified by PCR and have combined informativeness of PIC 0.95. , 1992, Genomics.

[8]  J. Weber,et al.  A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. , 1992, Human molecular genetics.

[9]  J. Hall Genomic imprinting and its clinical implications. , 1992, The New England journal of medicine.

[10]  Y. Nakamura,et al.  Fine-scale mapping of the gene responsible for multiple endocrine neoplasia type 1 (MEN 1). , 1992, American journal of human genetics.

[11]  J. Rastad,et al.  Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. , 1991, The Journal of clinical endocrinology and metabolism.

[12]  C. Junien,et al.  Uniparental paternal disomy in a genetic cancer-predisposing syndrome , 1991, Nature.

[13]  M. Fraccaro,et al.  Chromosome abnormalities in lymphocytes and fibroblasts of subjects with multiple endocrine neoplasia type 1. , 1991, Cancer genetics and cytogenetics.

[14]  Y. Nakamura,et al.  A detailed genetic map of the long arm of chromosome 11. , 1990, Genomics.

[15]  C. Larsson,et al.  Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Bouloux,et al.  Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. , 1989, The New England journal of medicine.

[17]  Y. Nakamura,et al.  Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. , 1989, The New England journal of medicine.

[18]  P. L. Chen,et al.  Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. , 1988, Science.

[19]  C. Larsson,et al.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma , 1988, Nature.

[20]  M. Brandi,et al.  Familial multiple endocrine neoplasia type I: a new look at pathophysiology. , 1987, Endocrine reviews.

[21]  J. Penney,et al.  Homozygotes for Huntington's disease , 1987, Nature.

[22]  Stephen H. Friend,et al.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma , 1986, Nature.

[23]  S. Baylin,et al.  Familial medullary thyroid carcinoma without associated endocrinopathies: A distinct clinical entity , 1986, The British journal of surgery.

[24]  T. P. Dryja,et al.  Expression of recessive alleles by chromosomal mechanisms in retinoblastoma , 1983, Nature.

[25]  S. Nordström,et al.  Dominantly inherited macular degeneration (Best's disease) in a homozygous father with 11 children , 1980, Clinical genetics.

[26]  A. Knudson Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[27]  P. Koller Chromosome Abnormalities , 1970, Nature.